Publication The combination of a novel immunomodulator with a regulatory T cell suppressing antibody (DTA-1) regress advanced stage B16F10 solid tumor by repolarizing tumor associated macrophages in situ. Banerjee S, Halder K, Ghosh S, et al. Oncoimmunology. 2015; 4 (3) : e995559. Download PDF